Etelcalcetide, A Novel Calcimimetic, Prevents Vascular Calcification in A Rat Model of Renal Insufficiency with Secondary Hyperparathyroidism
In conclusion, etelcalcetide and paricalcitol similarly atte nuated progression of SHPT in an adenine rat model of CKD. However, etelcalcetide differentially prevented vascular calcification, at least in part, due to reductions in serum FGF23, calcium, and phosphorus levels.
Source: Calcified Tissue International - Category: Orthopaedics Source Type: research
More News: Calcium | Chronic Kidney Disease | Dialysis | Diets | Hemodialysis | Hormones | Hyperparathyroidism | Nutrition | Orthopaedics | Phosphorus | Study | Urology & Nephrology